Radyus Research

Executive Summary

Radyus Research is a drug development organization based in Durham, NC, offering integrated project management services to biotech companies. Founded in 2020, the company specializes in advancing therapeutics across immunology, oncology, infectious, metabolic, and CNS diseases, with expertise in small molecules, antibodies, peptides, biologics, and gene therapy. Their services span lead optimization, preclinical efficacy, IND-enabling tox, CMC, and regulatory support. As a private, pre-clinical stage CRO/CDMO, Radyus supports clients in de-risking drug development and accelerating timelines. Given the growing demand for outsourced R&D and its comprehensive platform, Radyus is well-positioned to capture opportunities in the biotech ecosystem, though its success depends on client acquisition and project execution.

Upcoming Catalysts (preview)

• Q3 2026Securing new multi-year client contracts60% success
• Q4 2026Expansion of service offerings into cell and gene therapy50% success
• Q3 2026Strategic partnership with a mid-size biotech for IND-enabling studies45% success